Laborjournal<p>Das <a href="https://mstdn.science/tags/Biotech" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Biotech</span></a>-<a href="https://mstdn.science/tags/Startup" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Startup</span></a> HYpharm testet ein <a href="https://mstdn.science/tags/Nasenspray" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Nasenspray</span></a> mit Endolysin-Enzymen aus <a href="https://mstdn.science/tags/Phagen" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Phagen</span></a>, um folgenschwere Besiedelungen der Nasenschleimhaut durch Methicillin-resistente <a href="https://mstdn.science/tags/Staphylococcus" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Staphylococcus</span></a>-aureus (<a href="https://mstdn.science/tags/MRSA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>MRSA</span></a>)-<a href="https://mstdn.science/tags/Bakterien" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Bakterien</span></a> zu verhindern. <span class="h-card" translate="no"><a href="https://sueden.social/@realtobiasludwig" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>realtobiasludwig</span></a></span> hat die Details für uns: <a href="https://www.laborjournal.de/editorials/3057.php" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">laborjournal.de/editorials/305</span><span class="invisible">7.php</span></a></p>